Bender, B., Li, C., Marchand, M., Turner, D. C., Li, F., Vadhavkar, S., . . . Chanu, P. (2024). Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B‐cell non‐Hodgkin lymphoma. Clinical and translational science, 17(6), e13825-n/a. https://doi.org/10.1111/cts.13825
Chicago-Zitierstil (17. Ausg.)Bender, Brendan, et al. "Population Pharmacokinetics and CD20 Binding Dynamics for Mosunetuzumab in Relapsed/refractory B‐cell Non‐Hodgkin Lymphoma." Clinical and Translational Science 17, no. 6 (2024): e13825-n/a. https://doi.org/10.1111/cts.13825.
MLA-Zitierstil (9. Ausg.)Bender, Brendan, et al. "Population Pharmacokinetics and CD20 Binding Dynamics for Mosunetuzumab in Relapsed/refractory B‐cell Non‐Hodgkin Lymphoma." Clinical and Translational Science, vol. 17, no. 6, 2024, pp. e13825-n/a, https://doi.org/10.1111/cts.13825.